HSP-Molecular chaperones in cancer biogenesis and tumor therapy: An overview

Anticancer Research

Volumn 32, Issue 12, 2012, Pages 5139-5150

  Rappa, Francesca ^a,b   Farina, Felicia ^a   Zummo, Giovanni ^a   David, Sabrina ^a   Campanella, Claudia ^a,b   Carini, Francesco ^a   Tomasello, Giovanni ^a   Damiani, Provvidenza ^a   Cappello, Francesco ^a,b   De Macario, Everly Conway ^c   Macario, Alberto J L ^b,c  

^a UNIVERSITY OF PALERMO   (Italy)

^b Euro Mediterranean Institute of Science and Technology   (Italy)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer; Chaperonin; Chaperoning system; Chaperonology; Chaperonopathy; Chaperonopathy by mistake; Chaperonotherapy; HSP60; Molecular chaperones; Review

Indexed keywords

ANTINEOPLASTIC AGENT; CANCER VACCINE; CD14 ANTIGEN; CD40 ANTIGEN; CHAPERONE; CHAPERONIN 60; CISPLATIN; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 40; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 72; HEAT SHOCK PROTEIN 90; HEAT SHOCK PROTEIN E7; HEAT SHOCK PROTEIN PC 96; PACLITAXEL; RECOMBINANT HEAT SHOCK PROTEIN 70; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; APOPTOSIS; BRAIN TUMOR; BREAST CARCINOMA; BREAST TUMOR; CANCER CHEMOTHERAPY; CANCER THERAPY; CARCINOGENESIS; CENTRAL NERVOUS SYSTEM TUMOR; CHONDROSARCOMA; CHRONIC MYELOID LEUKEMIA; ENDOMETRIUM CANCER; GLIOBLASTOMA; HUMAN; KIDNEY CARCINOMA; LUNG CARCINOMA; MELANOMA; NONHUMAN; OSTEOSARCOMA; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN FOLDING; PROTEIN PROCESSING; REVIEW; SARCOMA; T LYMPHOCYTE; UTERINE CERVIX CANCER;

ANIMALS; CANCER VACCINES; CELL TRANSFORMATION, NEOPLASTIC; HEAT-SHOCK PROTEINS; HUMANS; MOLECULAR TARGETED THERAPY; NEOPLASMS;

EID: 84872538586     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (137)

1. Macario AJL and Conway de Macario E: The chaperoning system: Physiology and pathology. In: Experimental Medicine Reviews. Gerbino A, Crescimanno G and Zummo G (eds.). Plumelia. Vol. 2/3, pp. 9-21, 2008/2009. Available on-line at: http://www.unipa.it/giovanni.zummo.
2. Macario AJL, Cappello F, Zummo G and Conway de Macario E: Chaperonopathies of senescence and the scrambling of interactions between the chaperoning and the immune systems. Ann NY Acad Sci 1197: 85-93, 2010.
3. Brocchieri L, Conway de Macario E and Macario AJL: Chaperonomics, a new tool to study ageing and associated diseases. Mech Ageing Dev 128: 125-136, 2007.
4. Macario AJL and Conway de Macario E: Sick chaperones, cellular stress and disease. N Engl J Med 353: 1489-1501, 2005.
5. Asea A, Kraeft SK, Kurt-Jones EA, Stevenson MA, Chen LB, Finberg RW, Koo GC and Calderwood SK: HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine. Nat Med 6: 435-442, 2000.
6. Asea A, Rehli M, Kabingu E, Boch JA, Bare O, Auron PE, Stevenson MA and Calderwood SK: Novel signal transduction pathway utilized by extracellular HSP70: Role of toll-like receptor (TLR) 2 and TLR4. J Biol Chem 277: 15028-15034, 2002.
7. Gastpar R, Gross C, Rossbacher L, Ellwart J, Riegger J and Multhoff G: The cell surface-localized heat-shock protein 70 epitope TKD induces migration and cytolytic activity selectively in human NK cells. J Immunol 172: 972-980, 2004.
8. Pockley AG, Muthana M and Calderwood SK: The dual immunoregulatory roles of stress proteins. Trends Biochem Sci 33: 71-79, 2008.
9. Walsh D, Grantham J, Zhu XO, Wei Lin J, van Oosterum M, Taylor R and Edwards M: The role of heat shock proteins in mammalian differentiation and development. Environ Med 43: 79-87, 1999.
10. Voellmy R: Transduction of the stress signal and mechanisms of transcriptional regulation of heat shock/stress protein expression in higher eukaryotes. Crit Rev Eukaryot Gene Expr 4: 357-401, 1994.
11. Garrido C, Gurbuxani S, Ravagnan L and Kroemer G: Heatshock proteins: Endogenous modulators of apoptotic cell death. Biochem Biophys Res Commun 286: 433-442, 2001.
12. Kirchhoff SR, Gupta S and Knowlton AA: Cytosolic heat shock protein 60, apoptosis, and myocardial injury. Circulation 105: 2899-2904, 2002.
13. Di Felice V, Ardizzone N, Marcianò V, Bartolotta T, Cappello F, Farina F and Zummo G: Senescence-associated HSP60 expression in normal human skin fibroblasts. Anat Rec A Discov Mol Cell Evol Biol 284: 446-453, 2005.
14. Czarnecka AM, Campanella C, Zummo G and Cappello F: Mitochondrial chaperones in cancer: From molecular biology to clinical diagnostics. Cancer Biol Ther 5: 714-720, 2006.
15. Ghosh JC, Dohi T, Kang BH and Altieri DC: Hsp60 regulation of tumor cell apoptosis. J Biol Chem 283: 5188-5194, 2008.
16. Cappello F and Zummo G: HSP60 expression during carcinogenesis: Where is the pilot? Pathol Res Pract 202: 401-402, 2006
17. Ritossa F: A new puffing pattern induced by temperature shock and DNP in Drosophila. Experimentia 18: 571-573, 1962.
18. Lindquist S and Craig EA: The heat-shock proteins. Ann Rev Genet 22: 631-637, 1988.
19. Beckmann RP, Mizzen LA and Welch WJ: Interaction of HSP70 with newly synthesized proteins; implications for protein folding and assembly. Science 248: 850-854, 1990.
20. Freeman BC and Yamamoto KR: Disassembly of transcriptional regulatory complexes by molecular chaperones. Science 296: 2232-2235, 2002.
21. Kampinga HH, Hageman J, Vos MJ, Kubota H, Tanguay RM, Bruford EA, Cheetham ME, Chen B and Hightower LE: Guidelines for the nomenclature of the human heat shock proteins. Cell Stress Chaperones 14: 105-111, 2009.
22. Chandra D, Choy G and Tang DG: Cytosolic accumulation of HSP60 during apoptosis with or without apparent mitochondrial release: Evidence that its pro-apoptotic or pro-survival functions involve differential interactions with caspase-3. J Biol Chem 282: 31289-31301, 2007.
23. Soltys BJ and Gupta RS: Immunoelectron microscopic localization of the 60-kDa heat-shock chaperonin protein (Hsp60) in mammalian cells. Exp Cell Res 222: 16-27, 1996.
24. Soltys BJ and Gupta RS: Cell surface localization of the 60 kDa heat-shock chaperonin protein (Hsp60) in mammalian cells. Cell Biol Int 21: 315-320, 1997.
25. Piselli P, Vendetti S, Vismara D, Cicconi R, Poccia F, Colizzi V and Delpino A: Different expression of CD44, ICAM-1 and HSP60 on primary tumor and metastases of a human pancreatic carcinoma growing in SCID mice. Anticancer Res 20: 825-831, 2000.
26. Campanella C, Bucchieri F, Merendino AM, Fucarino A, Burgio G, Corona DF, Barbieri G, David S, Farina F, Zummo G, Conway de Macario E, Macario AJL and Cappello F: The odyssey of Hsp60 from tumor cells to other destinations includes plasma membrane-associated stages and Golgi and exosomal protein-trafficking modalities. PLoS One 7: e42008, 2012.
27. Rizzo M, Cappello F, Marfil R, Nibali L, Marino Gammazza A, Rappa F, Bonaventura G, Galindo-Moreno P, O'Valle F, Zummo G, Conway de Macario E, Macario AJL and Mesa F: Heat-shock protein 60 kDa and atherogenic dyslipidemia in patients with untreated mild periodontitis: A pilot study. Cell Stress Chaperones 17: 399-407, 2012.
28. Novo G, Cappello F, Rizzo M, Fazio G, Zambuto S, Tortorici E, Gammazza AM, Corrao S, Zummo G, Conway de Macario E, Macario AJL, Assennato P, Novo S and Li Volti G: Hsp60 and heme oxygenase-1 (Hsp32) in acute myocardial infarction. Transl Res 157: 285-292, 2011.
29. Thery C, Ostrowski M and Segura E: Membrane vesicle as conveyors of immune responses. Nat Rev 9: 581-593, 2009.
30. Schorey JS and Bhatnagar S: Exosome function: From tumor immunology to pathogen biology. Traffic 9: 871-881, 2008.
31. Vega VL, Rodriguez-Silva M, Frey T, Gehrmann M, Diaz JC, Steinem C, Multhoff G, Arispe N and De Maio A: Hsp70 translocates into the plasma membrane after stress and is released into the extracellular environment in a membrane-associated form that activates macrophages. J Immunol 180: 4299-4307, 2008.
32. Gastpar R, Gehrmann M, Bausero MA, Asea A, Gross C, Schroeder JA and Multhoff G: Heat shock protein 70 surface-positive tumor exosomes stimulate migratory and cytolytic activity of natural killer cells. Cancer Res 65: 5238-5247, 2005.
33. Cappello F, Caramori G, Campanella C, Vicari C, Gnemmi I, Zanini A, Spanevello A, Capelli A, Rocca GL, Anzalone R, Bucchieri F, D'Anna SE, Ricciardolo FL, Brun P, Balbi B, Carone M, Zummo G, Conway de Macario E, Macario AJL and Stefano AD: Convergent sets of data from in vivo and in vitro methods point to an active role of Hsp60 in chronic obstructive pulmonary disease pathogenesis. PLoS One 6: e28200, 2011.
34. Tomasello G, Rodolico V, Zerilli M, Martorana A, Bucchieri F, Pitruzzella A, Marino Gammazza A, David S, Rappa F, Zummo G, Damiani P, Accomando S, Rizzo M, Conway de Macario E, Macario AJL and Cappello F: Changes in immunohistochemical levels and subcellular localization after therapy and correlation and colocalization with CD68 suggest a pathogenetic role of Hsp60 in ulcerative colitis. Appl Immunohistochem Mol Morphol 19: 552-561, 2011.
35. Osterloh A, Meier Stiegen F, Veit A, Fleischer B, von Bonin A and Breloer M: Lipopolysaccharide free heat-shock protein 60 activates T-cells. J Biol Chem 279: 47906-47911, 2004.
36. Cappello F, Czarnecka AM, La Rocca G, Di Stefano A, Zummo G and Macario AJL: Hsp60 and Hsp10 as antitumor molecular agents. Cancer Biol Ther 6: 487-489, 2007.
37. Macario AJL and Conway de Macario E: The pathology of antistress mechanisms: Anew frontier. Stress 7: 243-249, 2004.
38. Macario AJL and Conway de Macario E: Chaperonopathies by defect, excess, or mistake. Ann NY Acad Sci 1113: 178-191, 2007.
39. Campanella C, Marino Gammazza A, Mularoni L, Cappello F, Zummo G and Di Felice V: A comparative analysis of the products of GroEL-1 gene from Chlamydia trachomatis serovar D and the HSP60 var1 transcript from Homo sapiens suggests a possible autoimmune response. Int J Immunogenet 36: 73-78, 2009.
40. Cappello F, Conway de Macario E, Di Felice V, Zummo G and Macario AJL: Chlamydia trachomatis infection and anti-Hsp60 immunity: The two sides of the coin. PLoS Pathog 5: e1000552, 2009.
41. Rodolico V, Tomasello G, Zerilli M, Martorana A, Pitruzzella A, Gammazza AM, David S, Zummo G, Damiani P, Accomando S, Conway de Macario E, Macario AJL and Cappello F: Hsp60 and Hsp10 increase in colon mucosa of Crohn's disease and ulcerative colitis. Cell StressChaperones 15: 877-884, 2010.
42. Marino Gammazza A, Bucchieri F, Grimaldi LM, Benigno A, Conway de Macario E, Macario AJL, Zummo G and Cappello F: The molecular anatomy of human HSP60 and its similarity with that of bacterial orthologs and acetylcholine receptor reveal a potential pathogenetic role of anti-chaperonin immunity in myasthenia gravis. Cell Mol Neurobiol 32: 943-947, 2012.
43. Cappello F, Marino Gammazza A, Zummo L, Conway de Macario E and Macario AJL: Hsp60 and AChR cross-reactivity in myasthenia gravis: An update. J Neurol Sci 292: 117-118, 2010.
44. Lemieux P, Oesterreich S, Lawrence JA, Steeg PS, Hilsenbeck SG, Harvey JM and Fuqua SAW: The small heat-shock protein Hsp27 increases invasiveness but decreases motility of breast cancer cells. Invasion Metastasis 17: 113-123, 1997.
45. Sanderson S, Valenti M, Gowan S, Patterson L, Ahmad Z, Workman P and Eccles SA: Benzoquinone ansamycin heat-shock protein 90 inhibitors modulate multiple functions required for tumor angiogenesis. Mol Cancer Ther 5: 522-532, 2006.
46. Zhao L, Liu L, Wang S, Zhang YF, Yu L and Ding YQ: Differential proteomic analysis of human colorectal carcinoma cell lines metastasis-associated proteins. J Cancer Res Clin Oncol 133: 771-782, 2007.
47. Calderwood SK, Theriault JR and Gong J: Message in a bottle: Role of the 70-kDa heat-shock protein family in antitumor immunity. Eur J Immunol 35: 2518-2527, 2005.
48. Cappello F and Zummo G: HSP60 expression during carcinogenesis: A molecular "Proteus" of carcinogenesis? Cell Stress Chap 10: 263-264, 2005.
49. Pearl LH, Prodromou C and Workman P: The Hsp90 molecular chaperone: An open and shut case for treatment. Biochem J 410: 439-453, 2008.
50. Cappello F, Bellafiore M, Palma A, David S, Marcianò V, Bartolotta T, Sciumè C, Modica G, Farina F, Zummo G and Bucchieri F: 60kDa chaperonin (HSP60) is overexpressed during colorectal carcinogenesis. Eur J Histochem 47: 105-110, 2003.
51. Cappello F, David S, Rappa F, Bucchieri F, Marasà L, Bartolotta TE, Farina F and Zummo G: The expression of HSP60 and HSP10 in large bowel carcinomas with lymph node metastase. BMC Cancer 5: 139, 2005.
52. Cappello F, Bellafiore M, Palma A, Marciano V, Martorana G, Belfiore P, Martorana A, Farina F, Zummo G and Bucchieri F: Expression of 60-kDa heat-shock protein increases during carcinogenesis in the uterine exocervix. Pathobiology 70: 83-88, 2002.
53. Cappello F, Rappa F, David S, Anzalone R and Zummo G: Immunohistochemical evaluation of PCNA, p53, HSP60, HSP10 and MUC-2 presence and expression in prostate carcinogenesis. Anticancer Res 23: 1325-1331, 2003.
54. Ito T, Kawabe R, Kurasono Y, Hara M, Kitamura H, Fujita K and Kanisawa M: Expression of heat shock proteins in squamous cell carcinoma of the tongue: An immunohistochemical study. J Oral Pathol Med 27: 18-22, 1998.
55. Cappello F, Di Stefano A, D'Anna SE, Donner CF and Zummo G: Immunopositivity of heat-shock protein 60 as a biomarker of bronchial carcinogenesis. Lancet Oncol 6: 816, 2005.
56. Cappello F, Di Stefano A, David S, Rappa F, Anzalone R, La Rocca G, D'Anna SE, Magno F, Donner CF, Balbi B and Zummo G: Hsp60 and Hsp10 down-regulation predicts bronchial epithelial carcinogenesis in smokers with chronic obstructive pulmonary disease. Cancer 107: 2417-2424, 2006.
57. Cappello F, David S, Ardizzone N, Rappa F, Marasà L, Bucchieri F and Zummo G: Expression of heat-shock proteins Hsp10, Hsp27, Hsp60, Hsp70 and Hsp90 in urothelial carcinoma of urinary bladder. J Cancer Mol 2: 73-77, 2006.
58. Lebret T, Watson RW, Molinié V, O'Neill A, Gabriel C, Fitzpatrick JM and Botto H: Heat-shock proteins HSP27, HSP60, HSP70, and HSP90: Expression in bladder carcinoma. Cancer 98: 970-977, 2003.
59. Beere, HM: Stressed to death: regulation of apoptotic signaling pathways by the heat-shock proteins. Sci STKE 2001: re1, 2001.
60. Vargas-Roig LM, Gaqo FE, Tello O, Aznar JC and Ciocca DR: Heat-shock protein expression and drug resistance in breast cancer patients treated with induction chemotherapy. Int J Cancer 79: 468-475, 1998.
61. Ciocca DR and Calderwood SK: Heat-shock proteins in cancer: Diagnostic, prognostic, predictive, and treatment implications. Cell StressChaperones 10: 86-103, 2005.
62. Sun J and Liao JK: Induction of angiogenesis by heat-shock protein 90 mediated by protein kinase Akt and endothelial nitric oxide syntethase. Aterioscler Thromb Vasc Biol 24: 2238-2244, 2004.
63. Pfosser A, Thalgott M, Büttner K, Brouet A, Feron O, Boekstegers P and Kupatt C: Liposomal Hsp90 cDNA induces neovascularization via nitric oxide in chronic ischemia. Cardiovasc Res 65: 728-736, 2005.
64. Keezer SM, Ivie SE, Krutzsch HC, Tandle A, Libutti SK and Roberts DD: Angiogenesis inhibitors target the endothelial cell cytoskeleton through altered regulation of heat-shock protein 27 and cofilin. Cancer Res 63: 6405- 6412, 2003.
65. Langdon SP, Rabiasz GJ, Hirst GL, King RJ, Hawkins RA, Smyth JF and Miller WR: Expression of the heat-shock protein HSP27 in human ovarian cancer. Clin Cancer Res 1: 1603-1609, 1995.
66. Lazaris ACh, Chatzigianni EB, Panoussopoulos D, Tzimas GN, Davaris PS and Golematis BCh: Proliferating cell nuclear antigen and heat-shock protein 70 immunolocalization in invasive ductal breast cancer not otherwise specified. Breast Cancer Res Treat 43: 43-51, 1997.
67. Nanbu K, Konishi I, Komatsu T, Mandai M, Yamamoto S, Kuroda H, Koshiyama M and Mori T: Expression of heat-shock proteins HSP70 and HSP90 in endometrial carcinomas. Correlation with clinicopathology, sex steroid receptor status, and p53 protein expression. Cancer 77: 330-338, 1996.
68. Pick E, Kluger Y, Giltnane JM, Moeder C, Camp RL, Rimm DL and Kluger HM: High Hsp90 expression is associated with decreased survival in breast cancer. Cancer res 67: 2932-2937, 2007.
69. Joly AL, Wettstein G, Mignot G, Ghiringhelli F and Garrido C: Dual role of heat-shock proteins as regulator of apoptosis and innate immunity. J Innate Immun 2: 238-247, 2010.
70. Cappello F, Bellafiore M, Palma A and Bucchieri F: Defective apoptosis and tumorigenesis: Role of p53 mutation and Fas/FasL system dysregulation. Eur J Histochem 46: 199-208, 2002.
71. Takayama S, Reed J C and Homma S: Heat-shock proteins as regulators of apoptosis. Oncogene 22: 9041-9047, 2003.
72. Garrido C, Bruey JM, Fromentin A, Hammann A, Arrigo AP and Solary E: HSP27 inhibits cytochrome c-dependent activation of procaspase-9. FASEB J 13: 2061-2070, 1999.
73. Pandey P, Saleh A, Nakazawa A, Kumar S, Srinivasula SM, Kumar V, Weichselbaum R, Nalin C, Alnemri ES, Kufe D and Kharbanda S: Negative regulation of cytochrome c-mediated oligomerization of Apaf-1 and activation of procaspase-9 by heat shock protein 90. EMBO J 19: 4310-4322, 2000.
74. Boldin MP, Goncharov TM, Goltsev YV and Wallach D: Involvement of MACH, a novel MORT1/FADD-interacting protease, in FAS/APO-1- and TNF receptor-induced cell death. Cell 85: 803-815, 1996.
75. Li H, Zhu H, Xu CJ and Yuan J: Cleavage of BID by caspase 8 mediates the mitochondrial damage in the FAS pathway of apoptosis. Cell 94: 491-501, 1998.
76. Charette SJ and Landry J: The interaction of HSP27 with Daxx identifies a potential regulatory role of HSP27 in FAS-induced apoptosis. Ann N Y Acad Sci 926: 126-131, 2000.
77. Lewis J, Devin A, Miller A, Lin Y, Rodriguez Y, Neckers L and Liu ZG: Disruption of HSP90 function results in degradation of the death domain kinase, receptor-interacting protein (RIP), and blockage of tumor necrosis factor-induced nuclear factor-kappaB activation. J Biol Chem 275: 10519-10526, 2000.
78. Garrido C, Gurbuxani S, Ravagnan L and Kroemer G: Heat-shock proteins: Endogenous modulators of apoptotic cell death. Biochem Biophys Res Commun 286: 433-442, 2001.
79. Samali A, Cai J, Zhivotovsky B, Jones DP and Orrenius S: Presence of a pre-apoptotic complex of pro-caspase-3, Hsp60 and Hsp10 in the mitochondrial fraction of Jurkat cells. EMBO J 18: 2040-2048, 1999.
80. Xanthoudakis, S, Roy S, Rasper D, Hennessey T, Aubin Y, Cassady R, Tawa P, Ruel R, Rosen A and Nicholson DW: Hsp60 accelerates the maturation of pro-caspase-3 by upstream activator proteases during apoptosis. EMBO J 18: 2049-2056, 1999.
81. Ghosh JC, Dohi T, Kang BH and Altieri DC: Hsp60 regulation of tumor cell apoptosis. J Biol Chem 283: 5188-5194, 2008.
82. Campanella C, Bucchieri F, Ardizzone NM, Gammazza AM, Montalbano A, Ribbene A, Di Delice V, Bellafiore M, David S, Rappa F, Marasà M, Peri G, Farina F, Czaenecka AM, Conway de Macario E, Macario AJL, Zummo G and Cappello F: Upon oxidative stress, the antiapoptotic Hsp60/procaspase-3 complex persist in mucoepidermoid carcinoma cells. Eur J Histochem 52: 221-228, 2008.
83. Cappello F, Conway de Macario E, Marasà L, Zummo G and Macario AJL: Hsp60 expression, new localizations, functions and perspective for cancer diagnosis and therapy. Cancer Biol Ther 7: 801-809, 2008.
84. Merendino AM, Bucchieri F, Campanella C, Marcianò V, Ribbene A, David S, Zummo G, Burgio G, Corona DF, Conway de Macario E, Macario AJL and Cappello F: Hsp60 is actively secreted by human tumor cells. PLoS One 5: e9247, 2010.
85. Multhoff G, Botzler C, Wiesnet M, Müller E, Meier T, Wilmanns W and Issels RD: A stress-inducible 72-kDa heat-shock protein (HSP72) is expressed on the surface of human tumor cells, but not on normal cells. Int J Cancer 61: 272-279, 1995.
86. Stangl S, Gehrmann M, Riegger J, Kuhs K, Riederer I, Sievert W, Hube K, Mocikat R, Dressel R, Kremmer E, Pockley AG, Friedrich L, Vigh L, Skerra A and Multhoff G: Targeting membrane heat-shock protein 70 (Hsp70) on tumors by cmHsp70.1 antibody. Proc Natl Acad Sci USA 108: 733-738, 2011.
87. Macario AJL and Conway de Macario E: Chaperonopathies and chaperonotherapy. FEBS let 581: 3681-3688, 2007.
88. Workman P: Pharmacogenomics in cancer drug discovery and development: Inhibitors of the Hsp90 molecular chaperone. Cancer Detect Prev 26: 405-410, 2002.
89. Maloney A and Workman P: Hsp90 as a new therapeutic target for cancer therapy: The story unfolds. Expert Opin Biol Ther 2: 3-24, 2002.
90. Modi S, Stopek A, Linden H, Solit D,Chandarlapaty S Rosen N, D'Andrea G, Dickler M, Moynahan ME, Sugarman S, Ma W, Patil S, Norton L, Hannah AL and Hudis C: Hsp90 inhibition is effective in breast cancer: A phase II trial of tanespimycin (17-AAG) plus trastuzumab in patients with HER2-positive metastatic breast cancer progressing on trastuzumab. Clin Cancer Res 17: 5132-5139, 2011.
91. Guo F, Rocha K, Bali P, Pranpat M, Fiskus W, Boyapalle S, Kumaraswamy S, Balasis M, Greedy B, Armitage ES, Lawrence N and Bhalla K: Abrogation of heat-shock protein 70 induction as a strategy to increase antileukemia activity of heat-shock protein 90 inhibitor 17-allylamino-demethoxy geldanamycin. Cancer Res 65: 10536-10544, 2005.
92. Demidenko ZN, Vivo C, Halicka HD, Li CJ, Bhalla K, Broude EV and Blagosklonny MV: Pharmacological induction of Hsp70 protects apoptosis-prone cells from doxorubicin: Comparison with caspase-inhibitor- and cycle-arrest-mediated cytoprotection. Cell Death Differ 13: 434-441, 2006.
93. Guo F, Sigua C, Bali P, George P, Fiskus W, Scuto A, Annavarapu S, Mouttaki A, Sondarva G, Wei S, Wu J, Djeu J and Bhalla K: Mechanistic role of heat-shock protein 70 in Bcr-Abl-mediated resistance to apoptosis in human acute leukemia cells. Blood 105: 1246-1255, 2005.
94. Ravagnan L, Gurbuxani S, Susin S A, Maisse C, Daugas E, Zamzami N, Mak T, Jaattela M, Penninger J M, Garrido C and Kroemer G: Heat-shock protein 70 antagonizes apoptosis-inducing factor. Nat Cell Biol 3: 839-843, 2001.
95. Schmitt E, Parcellier A, Gurbuxani S, Cande C, Hammann A, Morales MC, Hunt CR, Dix DJ, Kroemer RT, Giordanetto F, Jäättelä M, Penninger JM, Pance A, Kroemer G and Garrido C: Chemosensitization by a non-apoptogenic heat-shock protein 70-binding apoptosis-inducing factor mutant. Cancer Res 63: 8233-8240, 2003.
96. Schmitt E, Maingret L, Puig PE, Rerole AL, Ghiringhelli F, Hammann A, Solary E, Kroemer G and Garrido C: Heat-shock protein 70 neutralization exerts potent antitumor effects in animal models of colon cancer and melanoma. Cancer Res 66: 4191-4197, 2006.
97. Tanaka Y, Fujiwara K, Tanaka H, Maehata K and Kohno I: Paclitaxel inhibits expression of heat shock protein 27 in ovarian and uterine cancer cells. Int J Gynecol Cancer 14: 616-620, 2004.
98. Morino M, Tsuzuki T, Ishikawa Y, Shirakami T, Yoshimura M, Kiyosuke Y, Matsunaga K, Yoshikumi C and Saijo N: Specific regulation of Hsps in human tumor cell lines by flavonoids. In Vivo 11: 265-270, 1997.
99. Calderwood SK, Gong J, Theriault JR, Mambula SS and Gray PJ Jr.: Cell stress proteins: Novel immunotherapeutics. Novartis Found Symp 291: 115-131, 2008.
100. Noessner E, Gastpar R, Milani V, Brandl A, Hutzler PJ, Kuppner MC, Roos M, Kremmer E, Asea A, Calderwood SK and Issels RD: Tumor-derived heat shock protein 70 peptide complexes are cross-presented by human dendritic cells. J Immunol 169: 5424-5432, 2002.
101. Manjili MH, Henderson R, Chen X, Repasky E and Subjeck JR: HSP110-HER2/neu chaperone complex vaccine induces protective immunity against spontaneous mammary tumors in HER-2/neu transgenic mice. Proc AACR 44: 458, 2003.
102. Manjili MH, Henderson R, Wang XY, Chen X, Li Y, Repasky E, KazimL and Subjeck JR: Development of a recombinant HSP110-HER-2/neu vaccine using the chaperoning properties of HSP110. Cancer Res 62: 1737-1742, 2002.
103. Huang CY, Chen CA, Lee CN, Chang MC, Su YN, Lin YC, Hsieh CY and Cheng WF: DNA vaccine encoding heat-shock protein 60 co-linked to HPV16 E6 and E7 tumor antigens generates more potent immunotherapeutic effects than respective E6 or E7 tumor antigens. Gynecol Oncol 107: 404-412, 2007.
104. Chen W, Wang J, Shao C, Liu S, Yu Y, Wang Q and Cao X: Efficient induction of antitumor T cell immunity by exosomes derived from heat-shocked lymphoma cells. Eur J Immunol 36: 1598-1607, 2006.
105. Assikis VJ, Daliani D and Pagliaro L: Phase II study of an autologous tumor-derived heat-shock protein-peptide complex vaccine (HSPPC-96) for patients with metastatic renal cell carcinoma (mRCC). Proc ASCO 22: 386, 2003.
106. Belli F, Testori A, Rivoltini L, Maio M, Andreola G, Sertoli MR, Gallino G, Piris A, Cattelan A, Lazzari I, Carrabba M, Scita G, Santantonio C, Pilla L, Tragni G, Lombardo C, Arienti F, Marchianò A, Queirolo P, Bertolini F, Cova A, Lamaj E, Ascani L, Camerini R, Corsi M, Cascinelli N, Lewis JJ, Srivastava P and Parmiani G: Vaccination of metastatic melanoma patients with autologous tumor-derived heat-shock protein gp96-peptide complexes: Clinical and immunologic findings. J Clin Oncol 20: 4169-4180, 2002.
107. Di Pietro A, Tosti G, Ferrucci PF and Testori A: The immunological era in melanoma treatment: New challenges for heat shock protein-based vaccine in the advanced disease. Expert Opin Biol Ther 11: 1395-1407, 2011.
108. Kilmartin B and Reen DJ: HSP60 induces self-tolerance to repeated HSP60 stimulation and cross-tolerance to other proinflammatory stimuli. Eur J Immunol 34: 2041-2051, 2004.
109. Cappello F, Bellafiore M, David S, Anzalone R and Zummo G: Ten kilodalton heat-shock protein (HSP10) is overexpressed during carcinogenesis of large bowel and uterine exocervix. Cancer Lett 196: 35-41, 2003.
110. Mori D, Nakafusa Y, Miyazaki K and Tokunaga O: Differential expression of Janus kinase 3 (JAK3), matrix metalloproteinase 13 (MMP13), heat-shock protein 60 (HSP60), and mouse double minute 2 (MDM2) in human colorectal cancer progression using human cancer cDNA microarrays. Pathol Res Pract 201: 777-789, 2005.
111. He Y, Wu Y, Mou Z, Li W, Zou L, Fu T, Zhang A, Xiang D, Xiao H and Wang X: Proteomics-based identification of HSP60 as a tumor-associated antigen in colorectal cancer. Proteomics Clin Appl 1: 336-342, 2007.
112. Johansson B, Pourian MR, Chuan YC, Byman I, Bergh A, Pang ST, Norstedt G, Bergman T and Pousette A: Proteomic comparison of prostate cancer cell lines LNCaP-FGC and LNCaP-r reveals heat shock protein 60 as a marker for prostate malignancy. Prostate 66: 1235-1244, 2006.
113. Huang Q, Ye J, Huang Q, Chen W, Wang L, Lin W, Lin J and Lin X: Heat-shock protein 27 is overexpressed in tumor tissues and increased in sera of patients with gastric adenocarcinoma. Clin Chem Lab Med 48: 263-269, 2010.
114. Liu X, Ye L, Wang J and Fan D: Expression of heat-shock protein 90 beta in human gastric cancer tissue and SGD7901/VCR of MDR-type gastric cancer cell line. Chin Med J (Engl) 112: 1133-1137, 1999.
115. Yokota S, Yamamoto Y, Shimizu K, Momoi H, Kamikawa T, Yamaoka Y, Yanagi H, Yura T and Kubota H: Increased expression of cytosolic chaperonin CCT in human hepatocellular and colonic carcinoma. Cell Stress Chaperones 6: 345-350, 2001.
116. Shotar AM: p53 and heat shock protein 70 expressions in colorectal adenocarcinoma. Saudi Med J 26: 1602-1606, 2005.
117. Ogata M, Naito Z, Tanaka S, Moriyama Y and Asano G: Overexpression and localization of heat-shock proteins mRNA in pancreatic carcinoma. J Nippon Med Sch 67: 177-185, 2000.
118. Têtu B, Popa I, Bairati I, L'Esperance S, Bachvarova M, Plante M, Harel F and Bachvarov D: Immunohistochemical analysis of possible chemoresistance markers identified by microarrays on serous ovarian carcinomas. Mod Pathol 21: 1002-1010, 2008.
119. Athanassiadou P, Petrakakou E, Sakelariou V, Zerva C, Liossi A, Michalas S and Athanassiades P: Expression of p53, BCL-2 and heat-shock protein (Hsp72) in malignant and benign ovarian tumors. Eur J Cancer Prev 7: 225-231, 1998.
120. Cornford PA, Dodson AR, Parsons KF, Desmond AD, Woolfenden A, Fordham M, Neoptolemos JP, Ke Y and Foster CS: Heat-shock protein expression independently predicts clinical outcome in prostate cancer. Cancer Res 60: 7099-7105, 2000.
121. Takashi M, Katsuno S, Sakata T, Ohshima S and Kato K: Different concentrations of two small stress proteins, alphaB crystalline and HSP27 in human urological tumor tissues. Urol Res 26: 395-399, 1998.
122. Zhong L, Peng X, Hidalgo GE, Doherty DE, Stromberg AJ and Hirschowitz EA: Antibodies to HSP70 and HSP90 in serum in non-small cell lung cancer patients. Cancer Detect Prev 27: 285-290, 2003.
123. Thomas X, Campos L, Mounier C, Cornillon J, Flandrin P, Le QH, Piselli S and Guyotat D: Expression of heat-shock proteins is associated with major adverse prognostic factors in acute myeloid leukemia. Leuk Res 29: 1049-1058, 2005.
124. Chant ID, Rose PE and Morris AG: Analysis of heat-shock protein expression in myeloid leukaemia cells by flow cytometry. Br J Haematol 90: 163-168, 1995.
125. Hsu PL and Hsu SM: Abundance of heat shock proteins (HSP89, HSP60 and HSP27) in malignant cells of Hodgkin's disease. Cancer Res 58: 5507-5513, 1998.
126. Faried A, Sohda M, Nakajima M, Miyazaki T, Kato H and Kuwano H: Expression of heat-shock protein HSP60 correlated with the apoptotic index and patient prognosis in human oesophageal squamous cell carcinoma. Eur J Cancer 40: 2804-2811, 2004.
127. Kobayashi K, Yokota K, Yoshino T, Kawahara Y, Dey A, Hirai Y, Oguma K and Akagi T: Detection of Helicobacter pylori associated antigen and heat-shock protein 60 on follicular dendritic cells in the germinal centres of low-grade B-cell lymphoma of gastric mucosa-associated lymphoid tissue (MALT). J Clin Pathol 51: 396-398, 1998.
128. Kamishima T, Fukuda T, Usuda H, Takato H, Iwamoto H and Kaneko H: Carcinosarcoma of the urinary bladder: Expression of epithelial markers and different expression of heat-shock proteins between epithelial and sarcomatous elements. Pathol Int 47: 166-173, 1997.
129. Bajramovic JJ, Geutskens SB, Bsibsi M, Boot M, Hassankhan R, Verhulst KC and van Noort JM: The stress kit: A new method based on competitive reverse transcriptase-polymerase chain reaction to quantify the expression of human alphaB-crystallin, HSP27 and HSP60. Cell Stress Chap 5: 30-35, 2000.
130. Khalil AA: Biomarker discovery: A proteomic approach for brain cancer profiling. Cancer Sci 98: 201-213, 2007.
131. Bini L, Magi B, Marzocchi B, Arcuri F, Tripodi S, Cintorino M, Sanchez JC, Frutiger S, Hughes G, Pallini V, Hochstrasser DF and Tosi P: Protein expression profiles in human breast ductal carcinoma and histologically normal tissue. Electrophoresis 18: 2832-2841, 1997.
132. Hitotsumatsu T, Iwaki T, Fukui M and Tateishi J: Distinctive immunohistochemical profiles of small heat-shock proteins (heat-shock protein 27 and alpha B-crystallin) in human brain tumors. Cancer 77: 352-361, 1996.
133. Pignatelli D, Ferreira J, Soares P, Costa MJ and Magalhães MC: Immunohistochemical study of heat-shock proteins 27, 60 and 70 in the normal human adrenal and in adrenal tumors with suppressed ACTH production. Microsc Res Tech 61: 315-323, 2003.
134. Wang Q, An L, Chen Y and Yue S: Expression of endoplasmic reticulum molecular chaperone GRP94 in human lung cancer tissues and its clinical significance. Chin Med J (Engl) 115: 1615-1619, 2002.
135. Trieb K, Gerth R, Windhager R, Grohs JG, Holzer G, Berger P and Kotz R: Serum antibodies against the heat-shock protein 60 are elevated in patients with osteosarcoma. Immunobiology 201: 368-376, 2000.
136. Trieb K, Kohlbeck R, Lang S, Klinger H, Blahovec H and Kotz R: Heat-shock protein 72 expression in chondrosarcoma correlates with differentiation. J Cancer Res Clin Oncol 126: 667-670, 2000.
137. Cappello F, Conway de Macario E, Zummo G and Macario AJL: Immunohistochemistry of human HSP60 in health and disease: From autoimmunity to cancer. In: molecular chaperones. methods and protocols. series: methods in molecular biology. Calderwood SK and Prince TL (eds.) Humana Press, Springer. Vol. 787, 2011.